Motegi Tomoki, Fukuoka Rei, Tsuyuki Yuzo, Nagakubo Dai, Maeda Shingo, Yonezawa Tomohiro, Nishimura Ryohei, Momoi Yasuyuki
Veterinary Clinical Genetics and Information, Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan.
Veterinary Medical Center, The University of Tokyo, Tokyo 113-8657, Japan.
Vet Sci. 2025 Aug 8;12(8):743. doi: 10.3390/vetsci12080743.
Antimicrobial resistance is an increasing concern in companion animal practice; however, effective mitigation strategies in veterinary referral hospitals remain underexplored. This study investigated whether antimicrobial stewardship interventions guided by hospital-specific resistance patterns and prescribing data could improve resistance outcomes in a secondary care veterinary setting. Using data from 2016 to 2018 at the University of Tokyo Veterinary Medical Center, a targeted intervention was developed and implemented in early 2019, and its impact was evaluated until 2024. The intervention included Gram staining-based presumptive pathogen estimation, antibiogram-guided antimicrobial selection, clinician education, and regular feedback on prescribing practices. By 2020, overall antimicrobial use had reduced by over 50%, with marked reductions in the use of carbapenems and fluoroquinolones. By 2022, the prevalence of extended-spectrum β-lactamase-producing and spp. decreased from 53% to 24% and 78% to 7%, respectively. However, methicillin-resistant staphylococci remained prevalent in approximately 50% of cases. These findings suggest that hospital-tailored antimicrobial stewardship programs may be associated with meaningful reductions in resistance among gram-negative pathogens, although causality cannot be confirmed due to the observational study design. Moreover, additional strategies are necessary to address persistent resistance in gram-positive organisms.
抗菌药物耐药性在伴侣动物医疗实践中日益受到关注;然而,兽医转诊医院中有效的缓解策略仍未得到充分探索。本研究调查了以医院特定的耐药模式和处方数据为指导的抗菌药物管理干预措施是否能改善二级护理兽医环境中的耐药结果。利用东京大学兽医医学中心2016年至2018年的数据,在2019年初制定并实施了有针对性的干预措施,并对其影响进行评估直至2024年。该干预措施包括基于革兰氏染色的推定病原体估计、抗菌谱指导的抗菌药物选择、临床医生教育以及关于处方实践 的定期反馈。到202生年,抗菌药物的总体使用量减少了50%以上,碳青霉烯类和氟喹诺酮类药物的使用量显著减少。到20生2年,产超广谱β-内酰胺酶的 和 菌的流行率分别从53%降至24%和78%降至7%。然而,耐甲氧西林葡萄球菌在大约50%的病例中仍然普遍存在。这些发现表明,针对医院定制的抗菌药物管理计划可能与革兰氏阴性病原体耐药性的显著降低有关,尽管由于观察性研究设计无法确定因果关系。此外,还需要其他策略来解决革兰氏阳性菌中持续存在的耐药性问题。